display

The UK has approved the corona vaccine from Oxford University and pharmaceutical company Astra Zeneca.

The British regulatory authority for pharmaceuticals has approved the domestic vaccine, the Ministry of Health announced on Wednesday.

In studies, the agent had shown to be less effective than the already approved vaccine from Biontech and Pfizer, but it can be stored at refrigerator temperatures and is significantly cheaper.

The manufacturers have expressed the hope that the agent could become a “vaccine for the world”.

In Great Britain, the first vaccinations should take place on January 4th, as Health Minister Matt Hancock announced.

It was "brilliant to end 2020 with such a moment of hope," said Hancock.

Astra Zeneca boss Pascal Soriot described the day as important for "millions of people in the UK who will have access to this new vaccine".

It has been shown to be effective, well tolerated and easy to administer.

In addition, Astra Zeneca supplies it without profit.

According to the first study data, the vaccine should offer an average of 70 percent protection against Covid-19.

According to the group, the effectiveness could possibly be significantly higher with a special dosage.

At times there were doubts about the study design and the high effectiveness of the vaccine.

The Swedish-British group had therefore carried out additional investigations.

Unlike the vaccines from the Mainz company Biontech and the pharmaceutical company Pfizer as well as the US company Moderna, the British-Swedish preparation does not belong to the mRNA vaccines.

display

The active ingredient AZD1222 used by Astra Zeneca is based on the weakened version of a cold virus from chimpanzees.

It contains genetic material from a surface protein with which the Sars-CoV-2 pathogen docks onto human cells.

The agent works in two ways: It is supposed to promote the formation of specific antibodies as well as T cells - both are important for the immune system.

The UK pioneered coronavirus vaccination.

As the first country in Western Europe, the country granted emergency approval for the Biontech vaccine in early December.

The British government is relying primarily on the Astra Zeneca vaccine and has already ordered 100 million doses of it in advance.

The UK is one of the worst hit countries in Europe by the pandemic.

Almost 80,000 people have already died there with or from Covid-19.

The number of new infections has recently increased dramatically.

53,000 new cases were reported on Tuesday.